STAT

Opinion: HIV care is threatened by proposed changes to Medicare Part D

Proposed #Medicare changes that would lower drug prices could harm access to effective #HIV medications. That's a terrible trade-off.
A cocktail of premixed AIDS drugs. Source: Joe Raedle/Getty Images

Successfully treating HIV, and the even greater goal of ending the HIV pandemic, are based on a fundamental science-backed premise: that all people living with HIV should have early and uninterrupted access to effective antiretroviral medications that suppress the virus and keep it at undetectable levels for the rest of their lives. That premise for optimal HIV care, along with the great progress that has been made against HIV, is now threatened by proposed changes to Medicare aimed at lowering drug prices. That’s a terrible trade-off.

Effective treatment of HIV that begins as early as possible after infection and continues without interruption has well-established benefits. That is a powerful tool for ending the HIV epidemic.

You're reading a preview, sign up to read more.

More from STAT

STAT5 min readScience
In A Small Study, A Cancer Vaccine Assist Beats Immunotherapy Drugs Alone
The largest study to date of a "cancer vaccine" found that combining it with an immunotherapy drug kept patients’ tumors in check longer, on average, than the drug alone.
STAT3 min readSociety
Opinion: Compounding Pharmacies Need Stricter Federal Oversight
Compounding pharmacies are not bartenders mixing a gin and tonic. They produce essentially new drugs. The regulatory loophole that allows compounders to avoid necessary federal scrutiny must be closed.
STAT4 min read
Opinion: Opioid Overdose Should Be Treated Like Attempted Suicide: With An Emergency Hold
Having first responders provide a dose of buprenorphine after an overdose rescue is like having them provide Prozac to someone they just pulled from the ledge of a 20-story building…